Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Raw Materials: 2021-2024

Historic Raw Materials for Fortress Biotech (FBIO) over the last 4 years, with Dec 2024 value amounting to $3.2 million.

  • Fortress Biotech's Raw Materials fell 32.82% to $2.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.8 million, marking a year-over-year decrease of 32.82%. This contributed to the annual value of $3.2 million for FY2024, which is 31.12% down from last year.
  • Latest data reveals that Fortress Biotech reported Raw Materials of $3.2 million as of FY2024, which was down 31.12% from $4.6 million recorded in FY2023.
  • Fortress Biotech's Raw Materials' 5-year high stood at $6.5 million during FY2022, with a 5-year trough of $3.2 million in FY2024.
  • Its 3-year average for Raw Materials is $4.8 million, with a median of $4.6 million in 2023.
  • As far as peak fluctuations go, Fortress Biotech's Raw Materials increased by 15.83% in 2022, and later crashed by 31.12% in 2024.
  • Yearly analysis of 4 years shows Fortress Biotech's Raw Materials stood at $5.6 million in 2021, then rose by 15.83% to $6.5 million in 2022, then declined by 28.11% to $4.6 million in 2023, then tumbled by 31.12% to $3.2 million in 2024.